May 27
2:00 pm - 3:00 pm EDT

LOCAL TIME

Reengineering for solid tumors

CAR-Ts revolutionized the way blood cancers can be treated, but still haven’t really caught on in the market as physicians and patients consider vein-to-vein times, cost and manufacturing snafus. Now a large group of scientists are leading a well-funded drive to adapt this technology for solid tumors, while making the whole process much more economical for patients and payers. The winners will help revolutionize the field. And the race to be first has inspired a furious sprint to the finish line.

register now
register for the webinar

No cost to register, subject to confirmation

By registering for this event, you accept that you may receive direct communication from the sponsor(s).

If you are experiencing problems with your registration, please try the Zoom registration page.